The results of a novel study presented by Emory researchers during the International AIDS Society (IAS) Conference in Brisbane, Australia, have revealed exciting findings in the pursuit of an HIV cure. The study, led by Monica ...
Jul 25, 2023
0
4
An article published in the journal Biomedicine & Pharmacotherapy demonstrates the beneficial effects of consuming 500 milligrams (mg) per day of propolis for people living with HIV, the virus that causes AIDS. The authors ...
Jun 27, 2023
0
43
About 3.7 billion people carry the herpes simplex virus-1 in our nerve cells where it lies quiescent until triggered by stress or injury. When activated, its symptoms are usually mild, limited to cold sores or ulcers in our ...
Jun 22, 2023
0
31
A multi-institutional research group led by researchers from Tokyo Medical and Dental University (TMDU) has made a significant and promising step forward in our ability to treat human immunodeficiency virus type 1 (HIV-1), ...
Jun 21, 2023
0
6
A recently published article in Experimental Biology and Medicine addresses the mechanisms by which air pollution worsens COVID-19, highlighting the apparent protection offered by a dietary antioxidant, astaxanthin.
Apr 20, 2023
0
26
As of 2022, approximately 1.2 million people in the United States are living with HIV. Antiretroviral therapies have enabled many of these individuals to live productive, symptom-free lives, but a cure that permanently eliminates ...
Mar 28, 2023
0
51
Northwestern Medicine scientists have identified a new compound which could inform future HIV cure strategies, according to research published in Science Advances.
Mar 22, 2023
0
59
In 2020, bulevirtide (BLV) was conditionally approved for treating chronic hepatitis delta (CHD), an inflammation of the liver caused by hepatitis D virus (HDV). Now real-world studies of patients treated outside of clinical ...
Mar 20, 2023
0
45
A new dengue treatment that could become the first to prevent and treat the virus has proven effective in initial trials in monkeys, according to new research.
Mar 16, 2023
0
40
Two Chinese oral anti-SARS-CoV-2 drugs, Xiannuoxin (simnotrelvir/ritonavir) and VV116 (deuremidevir hydrobromide), were conditionally approved for marketing by China's National Medical Products Administration (NMPA) in late ...
Feb 7, 2023
0
18
